Join Clinical Trials
  • Login
  • Home
  • Clinical Trial Categories
  • Adults - 18 - 64
  • North Carolina
  • Fayetteville


Menu

Choose Which Database to Search - Volunteer Database - Clinical Trial Database Create an Account - VOLUNTEER Accounts - RECRUITER Accounts Account Login - Volunteers Login - Recruiters Login Join a Clinical Trial Clinical Trials by Category Clinical Trials by Location Submit a Clinical Trial Frequently Asked Questions Contact Us Sitemap Blog

Categories

    Healthy Volunteers Adults - 18 - 64 Youths - Birth - 17 Seniors - 65 + Expanded Access Compensated Trials Clinical Trials by Condition Trials by Drug Type Trials for Rare Conditions

Recent Listings

  • Post your clinical trial on JoinClinicalTrials.com

    Ellijay, Georgia 30536
    United States

    Post your clinical trial on JoinClinicalTrials.com

    05-09-2019 01:01PM

JoinClinicalTrials.com




Results

Post your clinical trial on JoinClinicalTrials.com
Hot

Post your clinical trial on JoinClinicalTrials.com


Ellijay, Georgia 30536
United States

Post your clinical trial on JoinClinicalTrials.com to reach thousands of viewer daily. Our Clinical Trial Listings have consistently proven to be an ...

Results 1 - 1 of 1
  • <<
  • <
  • 1
  • >
  • >>

  • Impact of Strength and Power Training on Golf Performance and Swing Biomechanics
    NCT04004468
    Conditions:   Resistance Training With Traditional Periodization Model;   Resistance Training With Conjugate Training Model
    Intervention:   Behavioral: Resistance Training
    Sponsor:   Methodist University, North Carolina
    Recruiting
  • A Study Evaluating Efficacy and Safety of Gepotidacin Compared With Ceftriaxone Plus Azithromycin in the Treatment of Uncomplicated Urogenital Gonorrhea
    NCT04010539
    Condition:   Gonorrhea
    Interventions:   Drug: Gepotidacin;   Drug: Ceftriaxone;   Drug: Azithromycin
    Sponsor:   GlaxoSmithKline
    Recruiting
  • Palbociclib in Real World Practice
    NCT03280303
    Conditions:   Advanced Breast Cancer;   Metastatic Breast Cancer
    Intervention:   Other: non-interventional
    Sponsor:   Pfizer
    Recruiting
  • Study of the Safety and Efficacy of Elagolix in Women With Polycystic Ovary Syndrome
    NCT03951077
    Condition:   Polycystic Ovary Syndrome
    Interventions:   Drug: Elagolix;   Drug: Placebo
    Sponsor:   AbbVie
    Recruiting
  • A Phase 2b Study of Icosabutate in Fatty Liver Disease
    NCT04052516
    Condition:   Non Alcoholic Steatohepatitis (NASH)
    Interventions:   Drug: Icosabutate;   Drug: Placebo
    Sponsor:   NorthSea Therapeutics B.V.
    Recruiting
  • A Study to Find Out How Safe Long-term Treatment With Fezolinetant is in Women With Hot Flashes Going Through Menopause
    NCT04003389
    Condition:   Hot Flashes
    Interventions:   Drug: fezolinetant;   Drug: placebo
    Sponsor:   Astellas Pharma Global Development, Inc.
    Recruiting
  • A Study to Find Out if Fezolinetant Helps Reduce Moderate to Severe Hot Flashes in Women Going Through Menopause
    NCT04003155
    Condition:   Hot Flashes
    Interventions:   Drug: fezolinetant;   Drug: placebo
    Sponsor:   Astellas Pharma Global Development, Inc.
    Recruiting
  • Study to Evaluate the Efficacy, Safety and Tolerability of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia (BPH)
    NCT03902080
    Condition:   Overactive Bladder
    Interventions:   Drug: Vibegron;   Drug: Placebo
    Sponsor:   Urovant Sciences GmbH
    Recruiting
  • A Phase 3 Study to Evaluate the Efficacy and Safety of MGL-3196 (Resmetirom) in Patients With NASH and Fibrosis
    NCT03900429
    Condition:   NASH - Nonalcoholic Steatohepatitis
    Interventions:   Drug: MGL-3196;   Drug: Placebo
    Sponsor:   Madrigal Pharmaceuticals, Inc.
    Recruiting
  • Patiromer for the Management of Hyperkalemia in Subjects Receiving RAASi Medications for the Treatment of Heart Failure (DIAMOND)
    NCT03888066
    Condition:   Hyperkalemia
    Interventions:   Drug: Patiromer;   Drug: Placebos
    Sponsors:   Relypsa, Inc.;   Vifor Pharma
    Recruiting
  • Active Recreation Through Community-Healthcare Engagement Study
    NCT03246763
    Conditions:   Childhood Obesity;   Quality of Life
    Intervention:   Behavioral: Integrated community-healthcare childhood obesity treatment
    Sponsor:   Duke University
    Recruiting
  • Randomized Trial Assessing Quinagolide Vaginal Ring for Endometriosis-related Pain
    NCT03692403
    Condition:   Endometriosis-related Pain
    Interventions:   Drug: Quinagolide 360 µg;   Drug: Quinagolide 720 µg;   Drug: Quinagolide 1080 µg;   Drug: Placebo
    Sponsor:   Ferring Pharmaceuticals
    Recruiting
  • Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy
    NCT03578081
    Condition:   Malignant Neoplasm
    Interventions:   Drug: Palonosetron Hydrochloride;   Drug: Ondansetron Hydrochloride;   Drug: Dexamethasone;   Drug: Fosaprepitant Dimeglumine;   Drug: Olanzapine;   Other: Placebo
    Sponsors:   Alliance for Clinical Trials in Oncology;   National Cancer Institute (NCI)
    Recruiting
  • A Study to Evaluate the Efficacy and Safety of TAK-906 in Adult Participants With Symptomatic Idiopathic or Diabetic Gastroparesis
    NCT03544229
    Conditions:   Diabetic Gastroparesis;   Idiopathic Gastroparesis
    Interventions:   Drug: TAK-906 Maleate;   Drug: TAK-906 Maleate Placebo
    Sponsor:   Millennium Pharmaceuticals, Inc.
    Recruiting
  • A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascular Events (MACE) and Efficacy Measures in Hypogonadal Men
    NCT03518034
    Conditions:   Hypogonadism;   Cardiovascular Diseases
    Interventions:   Drug: Testosterone;   Drug: Placebo
    Sponsors:   AbbVie;   Acerus Pharmaceuticals Corporation;   Allergan Sales, LLC;   Endo Pharmaceuticals;   Upsher-Smith Laboratories
    Recruiting
  • A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease
    NCT03466411
    Condition:   Crohn's Disease
    Interventions:   Drug: Guselkumab Dose 1;   Drug: Guselkumab Dose 2;   Drug: Guselkumab Dose 3;   Drug: Guselkumab Dose 4;   Drug: Guselkumab Dose 5;   Drug: Guselkumab;   Drug: Ustekinumab;   Drug: Placebo
    Sponsor:   Janssen Research & Development, LLC
    Recruiting
  • A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04
    NCT03383146
    Conditions:   Gastroparesis;   Diabetes Mellitus
    Interventions:   Drug: Relamorelin;   Drug: Placebo
    Sponsor:   Allergan
    Recruiting
  • Observational Study of Characteristics, Treatment and Outcomes With Severe Asthma in the United States (CHRONICLE)
    NCT03373045
    Condition:   Asthma
    Intervention:  
    Sponsors:   AstraZeneca;   Parexel;   MedImmune LLC
    Recruiting
  • A POC and Dose-Ranging Study of HTD1801 in PSC Patients
    NCT03333928
    Condition:   Primary Sclerosing Cholangitis (PSC)
    Interventions:   Drug: HTD1801;   Drug: Placebo
    Sponsor:   HighTide Biopharma Pty Ltd
    Recruiting
  • A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis 01
    NCT03285308
    Conditions:   Gastroparesis;   Diabetes Mellitus
    Interventions:   Drug: Relamorelin;   Drug: Placebo
    Sponsor:   Allergan
    Recruiting
  • Electronic Patient Reporting of Symptoms During Cancer Treatment
    NCT03249090
    Conditions:   Advanced Cancer;   Metastatic Cancer
    Interventions:   Other: Patient Self-Reporting of Symptoms;   Other: Usual Care Delivery
    Sponsors:   Alliance Foundation Trials, LLC.;   Patient-Centered Outcomes Research Institute;   University of North Carolina;   Mayo Clinic;   American Society of Clinical Oncology;   American Cancer Society, Inc.;   Dana-Farber Cancer Institute
    Recruiting
  • Efficacy and Safety of Oral Testosterone Undecanoate in Hypogonadal Men
    NCT03198728
    Condition:   Hypogonadism, Male
    Interventions:   Drug: SOV2012-F1;   Drug: AndroGel
    Sponsors:   Marius Pharmaceuticals;   Syneos Health
    Recruiting
  • AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH
    NCT03028740
    Condition:   Nonalcoholic Steatohepatitis
    Interventions:   Drug: Cenicriviroc;   Drug: Placebo
    Sponsor:   Tobira Therapeutics, Inc.
    Recruiting
  • Comparison of Operative to Monitoring and Endocrine Therapy (COMET) Trial For Low Risk DCIS
    NCT02926911
    Conditions:   DCIS;   Ductal Carcinoma in Situ
    Interventions:   Other: Guideline Concordant Care;   Other: Active Surveillance
    Sponsors:   Alliance Foundation Trials, LLC.;   Patient-Centered Outcomes Research Institute;   Duke University;   Dana-Farber Cancer Institute;   M.D. Anderson Cancer Center;   New York University;   Washington University School of Medicine
    Recruiting
  • Open-Label Extension and Safety Study for Participants With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144
    NCT02403323
    Condition:   Crohn Disease
    Intervention:   Drug: Etrolizumab
    Sponsor:   Hoffmann-La Roche
    Recruiting
  • A Study to Assess Whether Etrolizumab is a Safe and Efficacious Treatment for Participants With Moderately to Severely Active Crohn's Disease
    NCT02394028
    Condition:   Crohn Disease
    Interventions:   Drug: Etrolizumab;   Drug: Placebo
    Sponsor:   Hoffmann-La Roche
    Recruiting
  • Integrated Cancer Repository for Cancer Research
    NCT02012699
    Conditions:   Pancreatic Cancer;   Thyroid Cancer;   Lung Cancer;   Esophageal Cancer;   Thymus Cancer;   Colon Cancer;   Rectal Cancer;   GIST;   Anal Cancer;   Bile Duct Cancer;   Duodenal Cancer;   Gallbladder Cancer;   Gastric Cancer;   Liver Cancer;   Small Intestine Cancer;   Peritoneal Surface Malignancies;   Familial Adenomatous Polyposis;   Lynch Syndrome;   Bladder Cancer;   Kidney Cancer;   Penile Cancer;   Prostate Cancer;   Testicular Cancer;   Ureter Cancer;   Urethral Cancer;   Hypopharyngeal Cancer;   Laryngeal Cancer;   Lip Cancer;   Oral Cavity Cancer;   Nasopharyngeal Cancer;   Oropharyngeal Cancer;   Paranasal Sinus Cancer;   Nasal Cavity Cancer;   Salivary Gland Cancer;   Skin Cancer;   CNS Tumor;   CNS Cancer;   Mesothelioma;   Breast Cancer;   Leukemia;   Melanoma;   Sarcoma;   Unknown Primary Tumor;   Multiple Myeloma;   Ovarian Cancer;   Endometrial Cancer;   Vaginal Cancer;   Neuroendocrine Tumors;   Plasma Cell Dyscrasia;   Healthy Control
    Intervention:  
    Sponsor:   University of Nebraska
    Recruiting
  • International Hernia Mesh Registry
    NCT00622583
    Condition:   Hernia
    Intervention:  
    Sponsor:   Ethicon, Inc.
    Recruiting
  • Efficacy and Safety of Oral Ibrexafungerp (SCY-078) vs. Placebo in Subjects With Acute Vulvovaginal Candidiasis
    NCT03987620
    Condition:   Candida Vulvovaginitis
    Interventions:   Drug: Ibrexafungerp;   Drug: Placebo
    Sponsors:   Scynexis, Inc.;   PPD
    Recruiting
  • A Phase 3 Study of Solosec® for the Treatment of Trichomoniasis
    NCT03935217
    Condition:   Trichomonas Infection
    Interventions:   Drug: Secnidazole;   Drug: Placebo
    Sponsor:   Lupin Research Inc
    Recruiting
  • A Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-Care Treatment in Adolescent, Adult, and Elderly Non-Hospitalized Participants With Influenza A Infection Who Are at Risk of Developing Complications
    NCT03381196
    Condition:   Influenza A
    Interventions:   Drug: Pimodivir 600 mg;   Drug: Placebo;   Other: SOC Treatment
    Sponsor:   Janssen Research & Development, LLC
    Recruiting

Popular Now

  • Privacy Policy
  • Ad and Cookie Policy
  • Infringement Policy
  • Terms of Use
  • Email Policy
  • Contact Us
  • Post Clinical Trials
  • Join Clinical Trials
  • Volunteer Login
  • Recruiters Login
  • Frequently Asked Questions
  • Blog
  • Find Clinical Trials
  • Find Volunteers
  • Trials by Category
  • Trials by Location
  • Volunteers by Category
  • Volunteers by Location
All clinical trials are registered and certified with clinicaltrials.gov. Data via U.S. National Library of Medicine,U.S. National Institutes of Health, U.S. Department of Health & Human Services. JoinClinicaltrials.com (Aunica Media llc) is a free resource that provides individuals and companies with information regarding clinical trials that are being conducted nationwide. Aunica Media llc does not conduct clinical trials nor endorses them. Please consult your doctor or physician before participating. And Ye shall know the truth, and the truth shall make you free
©2001-2019 Aunica Media LLC